1-2 of 2
Benoit Marteyn
Close
Save search
Sort by
Journal Articles

Genetic Profiling and Deep IDH1 Mutation Clearance to ≤0.04% in Ivosidenib (AG-120)-Treated Patients with Mutant IDH1 Relapsed or Refractory and Untreated AML

Free
Richard M. Stone, MD, Sung Choe, PhD, Vickie Zhang, PhD, Benoit Marteyn, PhD, Virginie Penard-Lacronique, PhD, Hongfang Wang, PhD, Courtney D. DiNardo, MDMSc, Eytan M. Stein, MD, Amir T. Fathi, MD MD BS, Martin S. Tallman, MD, Hagop M. Kantarjian, MD, Eyal C. Attar, MD, Bin Wu, Stephane de Botton, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2684.
https://doi.org/10.1182/blood.V130.Suppl_1.2684.2684
Published: 2017
Journal Articles

Enasidenib induces acute myeloid leukemia cell differentiation to promote clinical response

Free
Clinical Trials & Observations
Michael D. Amatangelo, Lynn Quek, Alan Shih, Eytan M. Stein, Mikhail Roshal, Muriel D. David, Benoit Marteyn, Noushin Rahnamay Farnoud, Stephane de Botton, Olivier A. Bernard, Bin Wu, Katharine E. Yen, Martin S. Tallman, Elli Papaemmanuil, Virginie Penard-Lacronique, Anjan Thakurta, Paresh Vyas, Ross L. Levine
Journal: Blood
Blood (2017) 130 (6): 732–741.
https://doi.org/10.1182/blood-2017-04-779447
Published: 2017
Includes: Supplemental data